You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas: Cardiovascular
28 March 2024 - US-based screening and early detection specialist Polymedco LLC announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for the PATHFAST high-sensiti...
15 March 2024 - Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company, announced on Thursday that it has received a multi-year USD14m grant from National Institute on Drug Abuse (NIDA).The ...
13 March 2024 - Advanced Medical Solutions Group plc (AIM: AMS), a provider of tissue-healing technologies, declared on Wednesday that it plans to acquire Peters Surgical, a global provider of surgica...
13 March 2024 - Biopharmaceutical company AstraZeneca (LSE: AZN) announced on Wednesday that it has initiated THARROS, a groundbreaking Phase III trial exploring the potential of BREZTRI AEROSPHERE to...
13 March 2024 - Biotechnology company Silence Therapeutics (Nasdaq: SLN) on Wednesday disclosed positive topline 36-week data from the ongoing ALPACAR-360 phase 2 study of zerlasiran (SLN360). Zerlasi...
1 March 2024 - Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), a United States-based biotechnology company, announced on Thursday that it has named Kyle Jenne as its new executive vice president, chief gl...
Related Headlines
AstraZeneca invests USD300m to expand US manufacturing for cell therapy
Innovent Biologics announces CFO transition
Cardio Diagnostics appoints Dr Vimal Ramjee as Strategic Advisor
Acticor Biotech reports positive ACTIMIS clinical study results in Lancet Neurology Journal